e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Chronic cough: only symptom or disease?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The Efficacy of Bradanicline in Refractory Chronic Cough
Y. Kanemitsu (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), P. Butera (San Mateo , United States of America), B. Canning (Baltimore, United States of America), P. Dicpinigaitis (New York, United States of America), V. Iyer (Rochester, United States of America), M. Kitt (San Mateo , United States of America)
Source:
Virtual Congress 2020 – Chronic cough: only symptom or disease?
Session:
Chronic cough: only symptom or disease?
Session type:
Oral Presentation
Number:
4564
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kanemitsu (Manchester, United Kingdom), J. Smith (Manchester, United Kingdom), P. Butera (San Mateo , United States of America), B. Canning (Baltimore, United States of America), P. Dicpinigaitis (New York, United States of America), V. Iyer (Rochester, United States of America), M. Kitt (San Mateo , United States of America). The Efficacy of Bradanicline in Refractory Chronic Cough. 4564
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Successful Management of Chronic Cough
Source: ERS Live 2007
Year: 2007
Productive Cough, a Forgotten Phenotype of Refractory Chronic Cough
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Medication Effect on Acute Exacerbation and Mortality in Patients with Coexistent COPD and GERD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018
The Relationship Between Symptoms, Exacerbations And Treatment Response in Bronchiectasis
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020
Chronic hyperventilation in Asthma
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
“A Study of Infective Etiology in Patients With Acute Exacerbation of COPD”
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Chronic cough
Source: Breathe 2014; 10:349-352
Year: 2014
The effect of Octreotide in patients with refractory Chronic Cough
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Chronic refractory cough
Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines
Year: 2020
Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Progressive Phenotype in Chronic Hypersensitivity Pneumonitis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Upper Respiratory Symptoms in Patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020
Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Diagnosis and Treatment of Chronic Pulmonary Embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept